Impact of insulin resistance on post-procedural myocardial injury and clinical outcomes in patients who underwent elective coronary interventions with drug-eluting stents

JACC: Cardiovascular Interventions

Volumn 5, Issue 11, 2012, Pages 1159-1167

  Uetani, Tadayuki ^a   Amano, Tetsuya ^b   Harada, Kazuhiro ^a   Kitagawa, Katsuhide ^a   Kunimura, Ayako ^a   Shimbo, Yusaku ^a   Harada, Ken ^a   Yoshida, Tomohiro ^a   Kato, Bunichi ^a   Kato, Masataka ^a   Marui, Nobuyuki ^a   Nanki, Michio ^a   Hotta, Nigishi ^a   Ishii, Hideki ^c   Matsubara, Tatsuaki ^d   Murohara, Toyoaki ^c  

^a CHUBU ROSAI HOSPITAL   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

drug eluting stent; insulin resistance; interventional cardiology

Indexed keywords

CLOPIDOGREL; CREATINE KINASE MB; GLUCOSE; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PACLITAXEL; RAPAMYCIN; TICLOPIDINE; TRIACYLGLYCEROL; TROPONIN T; ZOTAROLIMUS;

ACUTE CORONARY SYNDROME; AGE; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIAC PATIENT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DEATH; DIET RESTRICTION; DRUG ELUTING STENT; ENZYME BLOOD LEVEL; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE INJURY; HUMAN; IN-STENT RESTENOSIS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STENT THROMBOSIS; TRIACYLGLYCEROL BLOOD LEVEL; VENOUS BLOOD;

AGED; CARDIOMYOPATHIES; DRUG-ELUTING STENTS; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE; TREATMENT OUTCOME;

EID: 84869457510     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2012.07.008     Document Type: Article

References (35)

1. C.F. Semenkovich Insulin resistance and atherosclerosis J Clin Invest 116 2006 1813 1822
2. C. Morisco, G. Lembo, B. Trimarco Insulin resistance and cardiovascular risk: new insights from molecular and cellular biology Trends Cardiovasc Med 16 2006 183 188
3. S. Basili, G. Pacini, M.T. Guagnano Insulin resistance as a determinant of platelet activation in obese women J Am Coll Cardiol 48 2006 2531 2538
4. S. Schenk, M. Saberi, J.M. Olefsky Insulin sensitivity: modulation by nutrients and inflammation J Clin Invest 118 2008 2992 3002
5. C. de Luca, J.M. Olefsky Inflammation and insulin resistance FEBS Lett 582 2008 97 105
6. S.J. Robins, H.B. Rubins, F.H. Faas VA-HIT Investigators Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT) Diabetes Care 26 2003 1513 1517
7. A. Tenenbaum, Y. Adler, V. Boyko Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease Am Heart J 153 2007 559 565
8. H.M. Lakka, T.A. Lakka, J. Tuomilehto, J. Sivenius, J.T. Salonen Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study Arch Intern Med 160 2000 1160 1168
9. J. Hirsh, D.L. Bhatt Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies Arch Intern Med 164 2004 2106 2110
10. T. Takagi, T. Akasaka, A. Yamamuro Impact of insulin resistance on neointimal tissue proliferation after coronary stent implantation: intravascular ultrasound studies J Diabetes Complications 16 2002 50 55
11. M. Nishimura, T. Tokoro, M. Nishida Association of insulin resistance with de novo coronary stenosis after percutaneous coronary artery intervention in hemodialysis patients Nephron Clin Pract 109 2008 c9 c17
12. A.A. Khattab, C.W. Hamm, J. Senges German Cypher Registry Prognostic value of the modified American College of Cardiology/American Heart Association lesion morphology classification for clinical outcome after sirolimus-eluting stent placement (results of the prospective multicenter German Cypher Registry) Am J Cardiol 102 2008 954 955
13. M.H. Shishehbor, S.S. Goel, S.R. Kapadia Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality J Am Coll Cardiol 52 2008 1041 1048
14. J. Herrmann Peri-procedural myocardial injury: 2005 update Eur Heart J 26 2005 2493 2519
15. D.L. Bhatt, E.J. Topol Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes Circulation 112 2005 906 915 discussion 923
16. T. Uetani, T. Amano, S. Kumagai Intracoronary electrocardiogram recording with a bare-wire system: perioperative ST-segment elevation in the intracoronary electrocardiogram is associated with myocardial injury after elective coronary stent implantation J Am Coll Cardiol Intv 2 2009 127 135
17. V. Randriamboavonjy, I. Fleming Insulin, insulin resistance, and platelet signaling in diabetes Diabetes Care 32 2009 528 530
18. K.K. Koh, S.H. Han, M.J. Quon Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions J Am Coll Cardiol 46 2005 1978 1985
19. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
20. K. Thygesen, J.S. Alpert, H.D. White Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction Eur Heart J 28 2007 2525 2538
21. D.E. Cutlip, S. Windecker, R. Mehran Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
22. I. Porto, J.B. Selvanayagam, W.J. Van Gaal Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound Circulation 114 2006 662 669
23. Y.J. Hong, G.S. Mintz, S.W. Kim Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis J Am Coll Cardiol Img 2 2009 458 468
24. T. Uetani, T. Amano, H. Ando The correlation between lipid volume in the target lesion, measured by integrated backscatter intravascular ultrasound, and post-procedural myocardial infarction in patients with elective stent implantation Eur Heart J 29 2008 1714 1720
25. T. Uetani, T. Amano, A. Kunimura The association between plaque characterization by CT angiography and post-procedural myocardial infarction in patients with elective stent implantation J Am Coll Cardiol Img 3 2010 19 28
26. T. Amano, T. Matsubara, T. Uetani Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance J Am Coll Cardiol Img 1 2008 39 45
27. T. Amano, T. Matsubara, T. Uetani Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions: integrated backscatter intravascular ultrasound study J Am Coll Cardiol 49 2007 1149 1156
28. R. Kumar, T.T. Lee, A. Jeremias Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients Am J Cardiol 100 2007 1187 1191
29. UK Prospective Diabetes Study Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
30. J.A. Dormandy, B. Charbonnel, D.J. Eckland PROactive Investigators Secondary prevention of macrovascular events in patients with type 2 diabetes in the proactive study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Lancet 366 2005 1279 1289
31. J.L. Chiasson, R.G. Josse, R. Gomis STOP-NIDDM Trial Research Group Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial JAMA 290 2003 486 494
32. J. Daemen, P. Wenaweser, K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
33. T. Kimura, T. Morimoto, Y. Nakagawa j-Cypher Registry Investigators Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation Circulation 119 2009 987 995
34. W.L. Miller, K.N. Garratt, M.F. Burritt, G.S. Reeder, A.S. Jaffe Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention Chest 125 2004 275 280
35. J.M. ten Berg, J.C. Kelder, M.J. Suttorp, F.W. Verheugt, H.W. Thijs Plokker Influence of planned six-month follow-up angiography on late outcome after percutaneous coronary intervention: a randomized study J Am Coll Cardiol 38 2001 1061 1069